Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran

References 

1. Abdul-Quader AS, Heckathorn DD, McKnight C, Bramson H, Nemeth C, Sabin K, et al. Effectiveness of respondent-driven sampling for recruiting drug users in New York City: Findings from a pilot study. Journal of Urban Health. 2006;83(3):459–476
2. Abdul-Quader AS, Heckathorn DD, Sabin K, Saidel T. Implementation and analysis of respondent driven sampling: Lessons learned from the field. Journal of Urban Health. 2006;83(6 Suppl.):i1–5
3. Alizadeh AH, Alavian SM, Jafari K, Yazdi N. Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan, Iran. World Journal of Gastroenterology. 2005;11(26):4085–4089
4. Ataei B, Kassaian N, Tayeri K, Farajzadegan Z. Hepatitis B and C among patients infected with human immunodeficiency virus in Isfahan-Iran: Seroprevalence and associated factors. European Journal of Internal Medicine. 2009;20:S218
   • Full-Text PDF (68 KB)
   • CrossRef
5. Azizi F, Jahed A, Hedayati M, Lankarani M, Bejestani HS, Esfahanian F, et al. Outbreak of exogenous Cushing's syndrome due to unlicensed medications. Clinical Endocrinology (Oxford). 2008;69(6):921–925
6. Center for Communicable Diseases Control Iran . Integrated bio-behavioral surveillance for HIV infection among injecting drug users in Iran (unpublished report). Tehran, Iran: Ministry of Health and Medical Education; 2008;
7. DeJong J, Mahfoud Z, Khoury D, Barbir F, Afifi RA. Ethical considerations in HIV/AIDS biobehavioral surveys that use respondent-driven sampling: Illustrations from Lebanon. American Journal of Public Health. 2009;99(9):1562–1567
   • CrossRef
8. Frost SD, Brouwer KC, Firestone Cruz MA, Ramos R, Ramos ME, Lozada RM, et al. Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: Recruitment dynamics and impact on estimates of HIV and syphilis prevalence. Journal of Urban Health. 2006;83(6 Suppl.):i83–i97
9. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World Journal of Gastroenterology. 2006;12(43):7025–7028
10. Imani R, Karimi A, Rouzbahani R, Rouzbahani A. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran. Eastern Mediterranean Health Journal. 2008;14(5):1136–1141
11. Johnston LG, Khanam R, Reza M, Khan SI, Banu S, Alam MS, et al. The effectiveness of respondent driven sampling for recruiting males who have sex with males in Dhaka, Bangladesh. AIDS and Behavior. 2008;12(2):294–304
    • CrossRef
12. Johnston LG, Malekinejad M, Kendall C, Iuppa IM, Rutherford GW. Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: Field experiences in international settings. AIDS and Behavior. 2008;12(4 Suppl.):S131–141
13. Johnston LG, Sabin K, Mai TH, Pham TH. Assessment of respondent driven sampling for recruiting female sex workers in two Vietnamese cities: Reaching the unseen sex worker. Journal of Urban Health. 2006;83(6 Suppl.):i16–i28
14. Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993;88(4):517–526
    • MEDLINE
    • CrossRef
15. Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005;19(Suppl. 2):S67–S72
16. Malekinejad M, Johnston LG, Kendall C, Kerr LR, Rifkin MR, Rutherford GW. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: A systematic review. AIDS and Behavior. 2008;12(4 Suppl.):S105–S130
17. Radfar , Nematollahi P, Tayeri K. Study on prevalence of HIV, HCV and HBV among IDU clients in IRANDOOST residential center, Isfahan. In: Paper presented at the first national congress of infection in addicts. Isfahan, Iran. 2007;
18. Radfar R, Pooya A, Meshkaty M, Fadai R, Soltanolkotaby MA. Pattern of behaviors and risks among injecting drug users coming in HAFTOON drop in center, Isfahan, Iran. In: Paper presented at the international conference on the reduction of drug related harm. Warsaw, Poland. 2007;
19. Radfar SR, Sadeghy S, Meshkaty M, Fadai R. An experience review: Study on ice breaking process among IDUs community in haftoon drop-in center (Isfahan, Iran). In: Paper presented at the international conference of drug related harm. Warsaw, Poland. 2007;
20. Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran. International Journal of Infectious Diseases. 2009;
21. Scott G. They got their program, and I got mine”: A cautionary tale concerning the ethical implications of using respondent-driven sampling to study injection drug users. International Journal of Drug Policy. 2008;19(1):42–51
22. Semaan S, Santibanez S, Garfein RS, Heckathorn DD, Des Jarlais DC. Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling. International Journal of Drug Policy. 2009;20(1):14–27
23. Shrestha S, Smith MW, Broman KW, Farzadegan H, Vlahov D, Strathdee SA. Multiperson use of syringes among injection drug users in a needle exchange program: A gene-based molecular epidemiologic analysis. Journal of Acquired Immune Deficiency Syndromes. 2006;43(3):335–343
24. Stormer A, Tun W, Guli L, Harxhi A, Bodanovskaia Z, Yakovleva A, et al. An analysis of respondent driven sampling with Injection Drug Users (IDU) in Albania and the Russian Federation. Journal of Urban Health. 2006;83(6 Suppl.):i73–i82
25. Tayeri K, Kasaee N, Fadaei Nobar R, Ataei B. Prevalence of HBV and HCV among HIV+ Drug Users in Isfahan, Iran. Journal of Isfahan University of Medical Sciences. 2009;26:273–278
26. Wattana W, van Griensven F, Rhucharoenpornpanich O, Manopaiboon C, Thienkrua W, Bannatham R, et al. Respondent-driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand. Drug and Alcohol Dependence. 2007;90(2–3):228–233
    • Abstract
    • Full Text
    • Full-Text PDF (181 KB)
    • CrossRef
27. Yeka W, Maibani-Michie G, Prybylski D, Colby D. Application of respondent driven sampling to collect baseline data on FSWs and MSM for HIV risk reduction interventions in two urban centres in Papua New Guinea. Journal of Urban Health. 2006;83(6 Suppl.):i60–i72
28. Zamani S, Ichikawa S, Nassirimanesh B, Vazirian M, Ichikawa K, Gouya MM, et al. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran. International Journal of Drug Policy. 2007;18(5):359–363